NO980032L - Biologisk aktiv blanding omfattende cyklosporin - Google Patents
Biologisk aktiv blanding omfattende cyklosporinInfo
- Publication number
- NO980032L NO980032L NO980032A NO980032A NO980032L NO 980032 L NO980032 L NO 980032L NO 980032 A NO980032 A NO 980032A NO 980032 A NO980032 A NO 980032A NO 980032 L NO980032 L NO 980032L
- Authority
- NO
- Norway
- Prior art keywords
- cyclosporine
- biologically active
- phase
- specific
- active mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Biologisk aktiv blanding basert på en L2-fase av et spesifikt monoglycerid, et spesifikt triglycerid og en spesifikk polar væske, og et syklosporin som er løst eller dispergert i nevnte L2-fase som den biologisk aktive substans. En fremgangsmåte for fremstilling av nevnte blanding, hvori syklosporinet blir tilsatt til L2-fasen før, under eller etter dannelsen av samme. Anvendelse av nevnte L2-fase for innkapsling av et syklosporin for fremstilling av et oralt administrer- bart preparat for anvendelse som et immunosuppressivt middel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9502472A SE504582C2 (sv) | 1995-07-06 | 1995-07-06 | Cyklosporinkomposition baserad på en L2-fas |
PCT/SE1996/000893 WO1997002042A1 (en) | 1995-07-06 | 1996-07-02 | Biologically active composition comprising cyclosporine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980032D0 NO980032D0 (no) | 1998-01-05 |
NO980032L true NO980032L (no) | 1998-03-03 |
Family
ID=20398887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980032A NO980032L (no) | 1995-07-06 | 1998-01-05 | Biologisk aktiv blanding omfattende cyklosporin |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0873133B1 (no) |
JP (1) | JPH11508592A (no) |
AT (1) | ATE213951T1 (no) |
AU (1) | AU6374596A (no) |
BR (1) | BR9609332A (no) |
CA (1) | CA2226219A1 (no) |
CZ (1) | CZ1998A3 (no) |
DE (2) | DE873133T1 (no) |
ES (1) | ES2123477T3 (no) |
NO (1) | NO980032L (no) |
SE (1) | SE504582C2 (no) |
WO (1) | WO1997002042A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE511313C2 (sv) | 1997-01-13 | 1999-09-06 | Gs Dev Ab | Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol |
EP1039893B1 (en) | 1997-12-10 | 2011-02-02 | Cyclosporine Therapeutics Limited | Pharmaceutical compositions containing an omega-3 fatty acid oil |
KR100602725B1 (ko) * | 1998-12-11 | 2006-07-20 | 파마솔루션스, 인코포레이티드 | 물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물 |
US8460693B2 (en) | 2001-11-08 | 2013-06-11 | Atrium Medical Corporation | Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US20060067977A1 (en) | 2004-09-28 | 2006-03-30 | Atrium Medical Corporation | Pre-dried drug delivery coating for use with a stent |
EP1811935B1 (en) | 2004-09-28 | 2016-03-30 | Atrium Medical Corporation | Heat cured gel and method of making |
US8312836B2 (en) | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US8574627B2 (en) | 2006-11-06 | 2013-11-05 | Atrium Medical Corporation | Coated surgical mesh |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
AU2006304590A1 (en) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
CN103120653B (zh) | 2007-04-04 | 2015-09-30 | 希格默伊德药业有限公司 | 一种口服药物组合物 |
EP3300723A1 (en) | 2009-05-18 | 2018-04-04 | Sigmoid Pharma Limited | Composition comprising oil drops |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
JP5911799B2 (ja) | 2009-08-12 | 2016-04-27 | シグモイド・ファーマ・リミテッドSigmoid Pharma Limited | ポリマーマトリックスおよび油相を含んで成る免疫調節組成物 |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
GB201304662D0 (en) | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
EP3215127B1 (en) * | 2014-11-07 | 2020-10-28 | Sublimity Therapeutics Limited | Compositions comprising cyclosporin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2907460A1 (de) * | 1978-03-07 | 1979-09-13 | Sandoz Ag | Neue resorbierbare galenische kompositionen |
SE457693B (sv) * | 1986-07-01 | 1989-01-23 | Drilletten Ab | Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas |
GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
-
1995
- 1995-07-06 SE SE9502472A patent/SE504582C2/sv not_active IP Right Cessation
-
1996
- 1996-07-02 CA CA002226219A patent/CA2226219A1/en not_active Abandoned
- 1996-07-02 EP EP96923154A patent/EP0873133B1/en not_active Expired - Lifetime
- 1996-07-02 DE DE0873133T patent/DE873133T1/de active Pending
- 1996-07-02 WO PCT/SE1996/000893 patent/WO1997002042A1/en not_active Application Discontinuation
- 1996-07-02 JP JP9505078A patent/JPH11508592A/ja active Pending
- 1996-07-02 DE DE69619700T patent/DE69619700T2/de not_active Expired - Fee Related
- 1996-07-02 AT AT96923154T patent/ATE213951T1/de not_active IP Right Cessation
- 1996-07-02 ES ES96923154T patent/ES2123477T3/es not_active Expired - Lifetime
- 1996-07-02 BR BR9609332A patent/BR9609332A/pt not_active Application Discontinuation
- 1996-07-02 CZ CZ9819A patent/CZ1998A3/cs unknown
- 1996-07-02 AU AU63745/96A patent/AU6374596A/en not_active Abandoned
-
1998
- 1998-01-05 NO NO980032A patent/NO980032L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9609332A (pt) | 1999-05-25 |
AU6374596A (en) | 1997-02-05 |
EP0873133B1 (en) | 2002-03-06 |
ES2123477T3 (es) | 2002-08-01 |
ES2123477T1 (es) | 1999-01-16 |
DE873133T1 (de) | 1999-05-06 |
EP0873133A1 (en) | 1998-10-28 |
WO1997002042A1 (en) | 1997-01-23 |
SE9502472D0 (sv) | 1995-07-06 |
ATE213951T1 (de) | 2002-03-15 |
CZ1998A3 (cs) | 1998-06-17 |
DE69619700D1 (de) | 2002-04-11 |
CA2226219A1 (en) | 1997-01-23 |
JPH11508592A (ja) | 1999-07-27 |
NO980032D0 (no) | 1998-01-05 |
DE69619700T2 (de) | 2002-10-24 |
SE504582C2 (sv) | 1997-03-10 |
SE9502472L (sv) | 1997-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980032L (no) | Biologisk aktiv blanding omfattende cyklosporin | |
GB2305122B (en) | Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate | |
NO20005431D0 (no) | Gelérbare farmasøytiske preparater | |
DK312583A (da) | Kortikoidholdigt praeparat til topisk applikation | |
IE873213L (en) | Galenical Formulation | |
JPS56135416A (en) | Pharmaceutical preparation for skin | |
DK0580817T3 (da) | Farmaceutisk præparat og fremgangsmåde til fremstilling deraf | |
FI884291A (fi) | Menetelmä biologisesti aktiivisen proteiinipitoisen aineen valmistamiseksi | |
SE8007639L (sv) | Nya tabletter for upplosning i tjocktarmen samt sett for framstellning derav | |
KR850007559A (ko) | 조절 펩타이드의 삽입식 제형 | |
BE853086A (fr) | Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis | |
DK1024795T3 (da) | Formuleringer med reguleret frigivelse | |
KR860000865A (ko) | 약제 제형의 제조방법 | |
DE60116302D1 (de) | Behandlung von seborrhoischer dermatitis | |
FR2553414B1 (fr) | Nouveaux benzenesulfonamides n-cyclises, leur procede de preparation et leur utilisation comme substance active de compositions pharmaceutiques | |
IE36563B1 (en) | New diazepine derivatives and processes for their production | |
ES8401929A1 (es) | Procedimiento de preparar derivados de p-acilaminofenol. | |
JPS54126722A (en) | Slow release antibiotic tablet | |
JPS5659707A (en) | Lasting antibiotic pharmaceutical and its preparation | |
JPS5257392A (en) | Immobilized enzyme using fibroin as carrier and method of preparing th e same | |
JPS5557510A (en) | Preparation of improved oil foundation | |
FR2449450A1 (fr) | Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension | |
Zaetz et al. | On disturbances of protein metabolism in burns | |
HUP9900942A2 (hu) | In situ képződő gyógyszerforma enzimek sebekre való juttatására | |
JPS5799519A (en) | Stable suppository and its preparation |